Albertsons Earnings Call: AI, Cash Returns Offset Headwinds

Albertsons Companies, Inc. ((ACI)) has held its Q4 earnings call. Read on for the main highlights of the call.

Albertsons’ latest earnings call struck a cautiously optimistic tone, as management showcased solid profitability, accelerating digital and loyalty trends, and a larger productivity program while openly flagging pressure from pharmacy headwinds and softer units in lower‑income shoppers. Leaders stressed that AI‑driven efficiencies and disciplined capital returns should offset near‑term drags and support modest growth into fiscal 2026.

Q4 Adjusted EBITDA and EPS Beat

Albertsons delivered Q4 adjusted EBITDA of $903 million, including roughly $68 million from the extra 53rd week, and adjusted EPS of $0.48, topping expectations despite a tough pharmacy backdrop. The beat underscored strong cost control and execution even as prescription activity and drug economics weighed on same‑store sales.

Full-Year Financial Performance

For fiscal 2025, identical sales rose 2% year over year and adjusted EBITDA reached $3.9 billion, signaling underlying resilience in a sluggish grocery environment. Management emphasized that productivity actions and disciplined pricing helped protect margins while still investing in customer value.

Shareholder Returns and Capital Allocation

The company returned more than $1.8 billion to shareholders in fiscal 2025, including about $1.5 billion of share repurchases and $322 million in dividends. It also raised the quarterly dividend 13% to $0.68 per share and refreshed a $2 billion buyback plan, reinforcing its commitment to ongoing cash returns.

Digital and Loyalty Momentum

Digital penetration surpassed 10% of sales in Q4, with digital revenue up 16% and nearly 90% of that growth coming from higher‑margin first‑party channels. Loyalty membership climbed 12% to over 51 million customers, which the company said is boosting visit frequency and basket size as offers become more personalized.

Productivity and AI Investment Acceleration

Albertsons announced a larger three‑year productivity program totaling $2.0 billion, backed by four major AI initiatives spanning digital experience, merchandising intelligence, labor, and supply chain. It rolled out its AI‑driven Gateway replenishment platform nationwide in February, aiming to cut waste, improve in‑stock levels, and free up capital.

Operational Fulfillment Strength

Store‑based fulfillment remains a key differentiator, with more than half of digital orders filled in under three hours. Management added that most delivery households now qualify for roughly 30‑minute flash delivery, the fastest‑growing digital offering and a lever to capture time‑sensitive, higher‑value baskets.

Balance Sheet and Refinancing Actions

Albertsons closed the year with net debt at 2.24 times adjusted EBITDA, leaving room to fund both investments and shareholder returns. The company also refinanced about $2.1 billion of bonds, extending maturities and improving flexibility as it navigates choppy consumer and pharmacy markets.

Pharmacy Headwinds and IRA Impact

Pharmacy performance was a major drag, knocking about 145 basis points off Q4 identical sales, with the Inflation Reduction Act accounting for roughly 105 basis points and GLP‑1 trends about 40 basis points. Management expects the IRA to continue to weigh on reported sales by around 150 basis points in fiscal 2026.

GLP-1 Growth Moderation

Growth in GLP‑1 prescriptions has cooled as payers tightened approval criteria and direct‑to‑consumer channels increased. This moderation contributed around 40 basis points of pressure on Q4 identical sales and is expected to remain a headwind into 2026, limiting pharmacy’s ability to offset other challenges.

Industry Unit Pressure and Lower-Income Cohorts

Grocery volumes stayed under pressure, especially among lower‑income customers who are cutting trips and cross‑shopping more aggressively for value. Albertsons warned that these trends, along with macro stress on budgets, will keep Q1 2026 sales below the full‑year outlook before conditions gradually improve.

Egg Deflation and Near-Term Sales Headwind

Deflation in key categories, particularly eggs, created a noticeable drag on Q4 revenue despite stable unit trends. The company expects this price deflation to continue into Q1 2026, masking some underlying volume resilience and contributing to a softer near‑term sales cadence.

Gross Margin Slightly Lower

Fourth‑quarter gross margin, excluding fuel and LIFO, came in at 27.2%, down 25 basis points from a year earlier. Management cited mix shift toward lower‑margin digital, along with pricing and mix dynamics, partially offset by productivity gains that helped keep profitability intact.

Recorded Opioid Settlement Framework Charge

Albertsons booked a $774 million charge tied to a proposed nationwide opioid settlement framework, to be paid over nine years. While non‑cash initially, the accrual represents a sizable legal and cash‑flow consideration that investors must factor into longer‑term capital allocation.

Higher Interest Expense and Extra-Week Effects

Interest expense climbed to $141 million in Q4 from $101 million a year earlier, reflecting higher borrowings and the extra 53rd week. The company also noted that adjusted EBITDA benefited by about $68 million from that additional week, an important adjustment when comparing growth rates.

Digital Mix Depressing Near-Term Margins

Rapid digital adoption is a double‑edged sword, as online orders now carry lower margins than in‑store purchases and are pressuring the overall gross margin rate. Management is leaning on its expanded productivity program and AI tools to offset these mix pressures while continuing to invest in price and convenience.

Guidance and Forward-Looking Outlook

For fiscal 2026, Albertsons guided to identical sales growth of 0% to 1%, or 1.5% to 2.5% excluding the expected IRA drag, with Q1 below that range but improving through the year. The company sees adjusted EBITDA of $3.85 billion to $3.925 billion, adjusted EPS between $2.22 and $2.32, and plans $2.0 billion to $2.2 billion of capital spending alongside a refreshed $2 billion buyback and higher dividend.

Albertsons’ call painted a picture of a retailer balancing near‑term macro and pharmacy headwinds with tangible progress in digital, loyalty, and AI‑enabled productivity. For investors, the story is one of steady, not spectacular, growth, but with disciplined leverage, rising shareholder returns, and the potential for earnings to grind higher as efficiency gains compound.